Diabetes Mellitus
Conditions
Keywords
glycemic regulation, metabolic control, sleep disorder, sexual dysfunction, depression
Brief summary
This study evaluates the metabolic control status, cardiovascular risk and frequency of comorbidities in diabetic patients followed in tertiary treatment centers in Turkey.
Detailed description
Diabetes mellitus is one of the most common chronic diseases worldwide.The prevalence of diabetes is increased significantly in Türkiye, from 7.2 % in 2002 to 13.7% in 2012. This increasing prevalence leads to serious public health problems and a significant economic burden. Many important diseases such as hypertension and dyslipidemia accompany the picture in diabetic patients. The optimal treatment of diabetes and prevention of diabetic complications, especially the cardiovascular outcomes, is utmost important. Although achieving glycemic targets in patients with diabetes is of great importance, blood glucose is not the only predictor of cardiovascular outcome in diabetes. Optimization of other metabolic parameters such as lipids, arterial blood pressure (ABP), and body weight as well as a healthy lifestyle are utmost important. Common problems in diabetic patients, such as sleep disorders and sexual dysfunction, affect glycemia regulation in these patients.There is little data on the frequency of these diseases in diabetic patients in Türkiye. In the TEMD-1 study conducted in 2017, the rates of diabetic patients achieving metabolic goals and the factors affecting these rates were revealed in Turkish patients with diabetes. The findings obtained in the current study will be compared with the findings in 2017, and in addition, the frequency of comorbidities such as sleep disorder, sexual dysfunction, and depression will be tried to be revealed.
Interventions
There is no intervention.
Sponsors
Gulhane School of Medicine
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients with type 1 or type 2 diabetes * Upper than 18 years old * To be under follow-up in the same center for at least one year.
Exclusion criteria
* Pregnant or lactation period * Younger than 18 years old * History of psychiatric disorders interfering cognition or compliance
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Glycemia control status of Turkish adult patients with diabetes mellitus | 7 days | Glycemia control will be defined as good control if the mean HbA1c level of patients \< 7% or poor control if the mean HbA1c level of patient between 7% and 9% and very poor control if the mean HbA1c level of patient \> 9% |
| Blood pressure control status of Turkish adult patients with diabetes mellitus | 7 days | Home blood pressure \<135/85 mmHg or office blood pressure \<140/90 mmHg will be defined as under control. |
| Lipid control status of Turkish adult patients with diabetes mellitus. | 7 days | Triglyceride \< 150 mg/dl, LDL-C \<55 mg/dl, \<70 mg/dl and \< 100 mg/dl according to the cardiovascular risk status, HDL-C \> 40 mg/dl for men, and HDL-C \> 50 mg/dl for women will be defined as under control. |
| Weight control status of Turkish adult patients with diabetes mellitus. | 7 days | Body mass index \< 30 kg/m2 will be defined as under control. Weight and height will be combined to report body mass index in kg/m2. |
Countries
Turkey (Türkiye)
Outcome results
None listed